ClinicalTrials.Veeva

Menu

Cardiovascular Risk Stratification in Covid-19 (CaVaR-Co19)

Oregon Health & Science University (OHSU) logo

Oregon Health & Science University (OHSU)

Status

Completed

Conditions

Covid19
Cardiovascular Risk Factor

Study type

Observational

Funder types

Other

Identifiers

NCT04555187
STUDY00021368

Details and patient eligibility

About

This retrospective double-cohort study seeks to:

  1. Describe the cardiovascular manifestations and electrophysiological (EP) substrate in COVID-19 infection and their association with clinical outcomes; and
  2. Develop a method of cardiovascular risk stratification in COVID-19

Enrollment

1,355 patients

Sex

All

Ages

18 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age >=18y
  • available data on Covid19 test in the electronic medical record (either positive or negative)

Exclusion criteria

  • no data of Covid19 test

Trial design

1,355 participants in 2 patient groups

Covid19-positive
Description:
Covid19 test positive. age \>= 18 y.
Covid19-negative
Description:
Covid19 test negative. age \>=18y

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems